The waiting list has become the product: management describes demand accumulating faster than the company can absorb it,
The model's full reasoning — Q2 2023 call → NOWe need to determine if management conveys that the company is currently accumulating a queue of demand it cannot yet serve, and that management is spending energy managing that queue rather than finding demand. From the transcript: Sharon Vitti says "demand for PT, for therapy, sports medicine, worksite injury and prevention programs remained strong in 2023. Our therapy referral volumes have exceeded pre-COVID levels." That indicates strong demand, but does it indicate a queue? She also says "hiring clinical FTEs will unlock our growth" and "provider growth is essential" and "we increased clinical FTE compared to last quarter" but they are still short. Chris Cox says "we are seeing providers in those markets that are already supported by this model able to spend more time operating at the top of their license" and "we have so much demand for therapy at ATI" (Joe Jordan said that). Also "we have so much demand for therapy at ATI, I think we'll be living with the contractors for a bit." That suggests demand is high and they can't fully serve it due to labor shortage. But is there a queue? They talk about referral volumes exceeding pre-COVID, but they are not explicitly saying they have a backlog of patients waiting. They talk about capacity utilization and productivity. They mention "reaching full clinic capacity utilization across our fleet will be a multi-year effort" and "we assume a steady growth in clinical FTE" to meet demand. The question is whether management conveys that demand is pressing in and they are managing the queue. They talk about "pipeline" as one of the three Ps, but that's referral pipeline, not a queue. They say "Our therapy referral volumes have exceeded pre-COVID levels." That indicates high demand, but not necessarily a queue. They also say "we have so much demand for therapy at ATI" - that suggests demand is there, but they are not able to fully serve it because of labor. However, they are not describing a specific queue of patients waiting to be scheduled. They are describing a shortage of clinicians, which limits their ability to see more patients. But is that a queue? They might be turning away patients or putting them on waitlists? Not explicitly stated.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| TT | Trane Technologies plc | Q3 2022 | 2022-11-02 | A |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| RMD | ResMed Inc. | Q4 2022 | 2022-08-11 | C |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| ZBRA | Zebra Technologies Corporation | Q2 2022 | 2022-08-02 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| WHF | WhiteHorse Finance, Inc. | Q1 2022 | 2022-05-10 | B+ |
| CLAR | Clarus Corporation | Q1 2022 | 2022-05-09 | B |
| CCK | Crown Holdings, Inc. | Q1 2022 | 2022-04-26 | C+ |
| CDMO | Avid Bioservices, Inc. | Q3 2022 | 2022-03-08 | B+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| HY | Hyster-Yale Materials Handling, Inc. | Q3 2021 | 2021-11-06 | D |
| HSY | The Hershey Company | Q3 2021 | 2021-10-28 | C |
| SLAB | Silicon Laboratories Inc. | Q3 2021 | 2021-10-27 | B |
| CROX | Crocs, Inc. | Q3 2021 | 2021-10-21 | B+ |
| CTSH | Cognizant Technology Solutions Corporati | Q2 2021 | 2021-07-28 | B |
| GLW | Corning Incorporated | Q2 2021 | 2021-07-27 | B+ |
| DOV | Dover Corporation | Q2 2021 | 2021-07-20 | B+ |
| SAND | Sandstorm Gold Ltd. | Q1 2018 | 2018-08-02 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| BPMC | Blueprint Medicines Corporation | Q1 2018 | 2018-05-02 | C+ |
| MTSI | MACOM Technology Solutions Holdings, Inc | Q1 2018 | 2018-02-06 | C+ |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| ENB | Enbridge Inc. | Q1 2016 | 2016-05-12 | B |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
TT · Q3 2022 → YESThe question is: Does management convey that the company is currently ACCUMULATING A QUEUE OF DEMAND IT CANNOT YET SERVE, and that they're managing that queue rather than finding demand? YES The transcript shows management describing a backlog of $6.4 billion that is "unprecedented" and "at elevated levels well into 2023," with Americas commercial HVAC backlog "up more than 70% year-over-year and more than 200% of historical norms." They note bookings remain "extremely high" with book-to-bill over 100%, and they are "managing" the queue through extended lead times, sequencing applied jobs, and accelerating revenue recovery from disruptions. While supply chain tightness is mentioned as a constraint, the language centers on demand already arriving and stacking up faster than capacity allows, with management focusing on processing, prioritizing, and expanding throughput rather than primarily attracting new demand. This aligns with the criteria for YES. No, the answer is not NO, as the queue is not merely routine or one-time. The posture is that demand is pressing in, and they are actively managing it. So the answer is YES. (borderline due to emphasis on share gains and innovation, but backlog and lead times dominate the narrative) . The final answer is YES. I think it's clear from the transcript that they are managing the queue.
SLAB · Q3 2021 → YESThe question is: Does management convey that the company is currently accumulating a queue of demand it cannot yet serve, and spending energy managing that queue rather than finding demand? YES The transcript shows management describing a widening gap where demand is increasing faster than supply can be ramped up, with explicit references to demand continuing to arrive and outpace capacity ("demand is continuing to increase at a faster rate," "demand increase much faster than we're able to increment up supply," "those gaps continue to widen"). They are actively managing this by prioritizing supply increments, equitable pricing to preserve relationships, and expanding throughput through new capacity and protocols, rather than primarily seeking new demand. This aligns with the criteria for a queue of unserved demand already accumulating and pressing on the company's ability to absorb it. The constraint stems from their manufacturing capacity (wafer supply), but the directional pressure and management focus on absorbing/expanding that demand confirm the posture.
CLAR · Q1 2022 → YESThe question is: Does management convey that the company is currently ACCUMULATING A QUEUE OF DEMAND IT CANNOT YET SERVE, and that they're managing that queue rather than finding demand? YES Management repeatedly describes a backlog of committed demand (strong order books, $10M in-transit inventory, $270M inventory purchases aligned to bookings, strong bookings across segments) that supply-chain, logistics, and capacity constraints are preventing them from converting into revenue today. They explicitly frame their current effort as “hand 10 million in demand… stuck in transit,” “prioritizing ammo, OEM, green box,” “allocating inventory,” “increasing capacity,” and “being scrappy” to serve the queue that is already arriving faster than they can absorb it. While some constraints are on inputs they buy, the transcript centers on their own customers and orders waiting in line and on their active management of that queue rather than on attracting new demand. The posture is therefore affirmative under the stated criteria.